alexa Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients.
Chemical Engineering

Chemical Engineering

Journal of Analytical & Bioanalytical Techniques

Author(s): Shields CL, Shields JA, Barrett J, De Potter P

Abstract Share this page

Abstract OBJECTIVE: To describe the clinical features of vasoproliferative tumors of the ocular fundus and to propose a comprehensive classification of these tumors. METHODS: A retrospective review of all cases that were diagnosed as acquired retinal hemangioma or vasoproliferative retinal tumor was conducted on the Ocular Oncology Service at Wills Eye Hospital, Philadelphia, Pa. RESULTS: There were 129 vasoproliferative tumors in 113 eyes of 103 patients. The tumors were classified as idiopathic in 84 eyes (74\%) and secondary to preexisting ocular disease in 29 (26\%). Subclassification into solitary (88 eyes), multiple (17 eyes), and diffuse (eight eyes) involvement was made. Of the 84 eyes with idiopathic tumors, 73 (87\%) had solitary tumors, five (6\%) had multiple tumors, and six (7\%) had diffuse tumors. The lesion was located in the inferior, inferotemporal, or temporal region of the fundus in 78\% and developed within 6 mm of the ora serrata retinae in 88\%. Associated vitreoretinal findings included intraretinal exudation (82\%), secondary exudative retinal detachment (48\%), vitreous cells (46\%), vitreous hemorrhage (21\%), preretinal macular fibrosis (31\%), and macular edema (18\%). Of the 29 eyes with secondary tumors, the tumor was solitary in 15 (52\%), multiple in 12 (41\%), and diffuse in two (7\%). The most common preexisting ocular disease included intermediate uveitis (pars planitis) in eight eyes (28\%), retinitis pigmentosa in six (21\%), toxoplasmic retinitis in two (7\%), toxocariasis in two (7\%), retinochoroidal coloboma in two (7\%), and traumatic chorioretinopathy in two (7\%). Retinal pigment epithelial hyperplasia was a prominent feature that was adjacent to 58\% of the secondary tumors. Overall, management of the 129 tumors consisted of observation in 63 (49\%), cryotherapy in 54 (42\%), laser photocoagulation in seven (5\%), plaque radiotherapy in three (2\%), and other modes of treatment in two (2\%). CONCLUSIONS: Vasoproliferative retinal tumors can be idiopathic, or they can develop secondary to congenital, inflammatory, vascular, traumatic, dystrophic, and degenerative ocular diseases. They can produce a variety of complications. Awareness and recognition of these tumors and differentiation from other retinal vascular tumors are important.
This article was published in Arch Ophthalmol and referenced in Journal of Analytical & Bioanalytical Techniques

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords